Indo National Invests Rs 80 Lakh in Medcuore, Stake at 57.48%
Indo National Limited invested Rs 80,00,000 in Medcuore Medical Solutions, acquiring 871 equity shares at Rs 9,187 per share. This additional 2.69% stake increases the company's total holding to 57.48% on a fully diluted basis. The investment aims to facilitate business growth and generate revenue.
*this image is generated using AI for illustrative purposes only.
Indo National Limited has made an additional primary investment of Rs. 80,00,000 in Medcuore Medical Solutions Private Ltd (MMSPL) through subscription to equity shares. The disclosure was made under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed on 13 May 2026. This investment follows an earlier intimation dated January 22, 2026, indicating a continued strategic commitment to MMSPL.
Acquisition Details
The transaction involved the acquisition of 871 equity shares at a price of Rs. 9,187 per share, determined on the basis of a valuation report issued by a registered valuer. The consideration was settled entirely in cash. The additional 2.69% stake acquired through this investment has raised Indo National's total shareholding in MMSPL to 57.48% of the paid-up share capital on a fully diluted basis.
Key parameters of the transaction are summarised below:
| Parameter: | Details |
|---|---|
| Investee Company: | Medcuore Medical Solutions Private Ltd |
| Investment Amount: | Rs. 80,00,000 |
| Number of Shares Acquired: | 871 shares |
| Price Per Share: | Rs. 9,187 |
| Additional Stake Acquired: | 2.69% |
| Total Shareholding Post-Acquisition: | 57.48% |
| Mode of Consideration: | Cash |
| Related Party Transaction: | No |
| Regulatory Approvals Required: | Nil |
| Indicative Completion Timeline: | Upto FY 2027-28 |
About Medcuore Medical Solutions Private Ltd
Medcuore Medical Solutions Private Ltd is engaged in the manufacturing, distribution, and provision of services related to Air Monitoring Systems and Air Purifiers. The company was incorporated on 07 June 2020 and operates in India. The acquisition does not fall under a related party transaction, and none of the promoter, promoter group, or group companies of Indo National have any interest in MMSPL.
MMSPL's turnover over the last three fiscal years is presented below:
| Fiscal Year: | Turnover |
|---|---|
| FY 25: | Rs. 35,41,484 |
| FY 24: | Rs. 47,68,000 |
| FY 23: | Rs. 83,54,000 |
Strategic Rationale
Indo National has stated that the object of the acquisition is to facilitate business growth, generate revenue, and earn profit through the expansion of business. No governmental or regulatory approvals are required for this acquisition. The indicative time period for the completion of the overall acquisition process extends up to FY 2027-28.
Historical Stock Returns for Indo National
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.33% | -13.72% | +15.56% | -10.17% | -25.55% | -2.01% |
Given MMSPL's declining turnover over the past three fiscal years, what specific operational or strategic changes is Indo National planning to reverse this trend and achieve profitability by FY 2027-28?
Will Indo National seek majority board control or management restructuring at MMSPL following its 57.48% majority stake, and how might this impact MMSPL's day-to-day operations?
How does Indo National's investment in the air monitoring and purification sector align with its core business, and could this signal a broader diversification strategy into healthcare or environmental technology?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
